TREA

79307220 - ARVIDAL

Follow

Information

  • Trademark
  • 79307220
  • Serial Number
    79307220
  • Filing Date
    December 11, 2020
    4 years ago
  • Transaction Date
    April 05, 2023
    a year ago
  • Status Date
    March 14, 2022
    2 years ago
  • Published for Opposition Date
    November 02, 2021
    3 years ago
  • Location Date
    March 14, 2022
    2 years ago
  • Status Code
    604
  • Current Location
    TTAB
    Employee Name
    PIERCE, ALEXANDRA E
  • Attorney Docket Number
    162429-00101
    Attorney Name
    MATTHEW A HOMYK
    Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
ARVIDAL
Case File Statements
  • GS0051: pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections
Case File Event Statements
  • 4/5/2023 - a year ago
    35 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT
  • 3/14/2023 - a year ago
    34 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/14/2023 - a year ago
    33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/31/2022 - 2 years ago
    32 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 10/12/2022 - 2 years ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/12/2022 - 2 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/15/2022 - 2 years ago
    29 - ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION Type: MAB4
  • 3/14/2022 - 2 years ago
    28 - ABANDONMENT - AFTER INTER PARTES DECISION Type: ABN4
  • 3/14/2022 - 2 years ago
    27 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 3/14/2022 - 2 years ago
    26 - OPPOSITION SUSTAINED NO. 999999 Type: OP.S
  • 12/13/2021 - 3 years ago
    25 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/22/2021 - 3 years ago
    24 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 11/16/2021 - 3 years ago
    23 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 11/16/2021 - 3 years ago
    22 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 11/15/2021 - 3 years ago
    21 - OPPOSITION PAPERS RECEIVED AT TTAB Type: OPPF
  • 11/2/2021 - 3 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/2/2021 - 3 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/13/2021 - 3 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/28/2021 - 3 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/27/2021 - 3 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/27/2021 - 3 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/27/2021 - 3 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/24/2021 - 3 years ago
    13 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/2/2021 - 3 years ago
    12 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/2/2021 - 3 years ago
    11 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/2/2021 - 3 years ago
    10 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/1/2021 - 3 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/24/2021 - 3 years ago
    8 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/4/2021 - 3 years ago
    7 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/3/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/13/2021 - 3 years ago
    5 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 5/10/2021 - 3 years ago
    4 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 4/2/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/29/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/25/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR